Results 131 to 140 of about 65,548 (249)

Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer. [PDF]

MedComm (2020)
Gupta MK, Vadde R, Nagaraju GP.
europepmc   +1 more source

Baicalein Sensitizes Radioresistant BT549 and MCF7‐R Breast Cancer Cells by Modulating Rac1 Signaling

Phytotherapy Research, EarlyView.
ABSTRACT Radioresistance remains a key barrier in breast cancer (BC) treatment. Baicalein, a flavonoid from Scutellaria baicalensis, has shown potential to enhance radiosensitivity. This study investigates its efficacy and mechanism in radioresistant BC models. Radioresistant BC cell models were established via fractionated irradiation and validated by
Zitong Zhao, Zhangyun Li, Quanzhou Peng, Shuqun Zhang   +3 more
wiley   +1 more source

Ruta graveolens L. in Evidence‐Based Phytotherapy: Pharmacological Activities, Bioactive Compounds and Safety

Phytotherapy Research, EarlyView.
Graphical representation of ethnomedical uses, major bioactive compounds, pharmacological potential and toxicological risks of Ruta graveolens L. ABSTRACT Ruta graveolens L. is widely used in traditional European, Asian, African, and South American medicine for digestive, nervous, cardiovascular, respiratory, and reproductive disorders.
Tetiana Serhiienko, Victoriya Georgiyants, Liudas Ivanauskas, Olha Mykhailenko   +3 more
wiley   +1 more source

Single-cell analysis and EpCAM-based microfluidic chip detection of PD-L1 on circulating tumor cells for prognostic prediction in epithelial ovarian cancer. [PDF]

Front Oncol
Zhang L, Lyu H, Tong X, Lou S.
europepmc   +1 more source

Plant‐Derived Extracellular Vesicles: Biogenesis, Function, and Application in Cancer Immunotherapy

Phytotherapy Research, EarlyView.
This illustration shows the biogenesis pathways of edible and medicinal plant‐derived extracellular vesicles (PDEVs) and their therapeutic effects following uptake in the human body, highlighting their potential for application in cancer immunotherapy. ABSTRACT Plant‐derived extracellular vesicles (PDEVs) are nanoscale, lipid bilayer‐enclosed vesicles ...
Guosheng Li, Mengyu Li, Shujing Liu, Yuan Wei, Chen Wang   +4 more
wiley   +1 more source

Ovarian Cancer Stem Cells: Mechanisms of Progression and Therapeutic Strategies. [PDF]

Oncol Res
Wu J, Zhang Z, Chan KY, Lau TS, Wang CC.
europepmc   +1 more source

Regulating Lipid Metabolism in Cancer: The Therapeutic Potential of Traditional Chinese Medicine

Phytotherapy Research, EarlyView.
By regulating the reprogramming of lipid metabolism in tumor cells, TCM provides a novel strategy for antitumor therapy with reduced toxicity and enhanced efficacy. ABSTRACT Lipid metabolic reprogramming is a key feature of tumor cells to adapt to the microenvironment and plays an important role in tumor growth, invasion, and metastasis.
Yufeng Gao, Huiming Huang, Xuejiao Wei, Xiaoxue Wang, Wanying Xie, Xinyu Qiu, Fei Wang, Zhuguo Wang, Ruoxin Zhang, Yilin Cai, Changhai Qu, Zhongdong Hu   +11 more
wiley   +1 more source

Clinicopathological Spectrum of Ovarian Tumors and Diagnostic Utility of Cancer Antigen 125 (CA-125): An Observational Study From Eastern India. [PDF]

Cureus
Choudhary A, Paswan MK, Jamaiyar A.
europepmc   +1 more source

Peptide Terminated Polymer Brush Nanomaterials for Label‐Free Separation of Cancer Cells Based on Relative Adhesion

Small, EarlyView.
Horan et al. demonstrate that RGD peptide‐functionalized poly(ethylene glycol) brush films synthesized in polydimethylsiloxane microfluidic channels by surface‐initiated atom transfer radical polymerization enable label‐free separation of melanoma and ovarian cancer cells based on differential integrin expression.
Stephen Horan, Anita Wdowicz, Nathan Feely, Peng Li, Oya Tagit, Wenxin Wang, Gil U Lee   +6 more
wiley   +1 more source

Profiling tumor immune microenvironment of epithelial ovarian carcinoma. [PDF]

Oncoimmunology
Dehghani-Ghobadi Z, Dionellis VS, Traber C, Moore JS, Samartzis N, Ryser S, Kalaitzopoulos DR, Liaudet N, Ferreira C, Du Bois V, Stancl P, Karlic R, Choschzick M, Noske A, Sandoval JL, Samartzis EP, Labidi-Galy I.   +16 more
europepmc   +1 more source